TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Incidence of subjective lip numbness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the number of Ki67+ nuclei
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in CD8 and CD45RO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lower sum scores in ALA-treated plaques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete resolution of CT lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of seizure recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anaesthetic elimination (FA/FAO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergence time (time to open eyes)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haemodynamics (HR, systolic and diastolic BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PASI mean percent improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Median cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Birth <35 weeks
Endpoint domain: Mortality/survival
Primary endpoint: flare measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of new lesions developed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients without new lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of postoperative hydrocele
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in sperm motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Reduction in size of pressure ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin resistance measured by HOMA index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of total score on Rutter Parent Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of total score on Achenbach Child Behavior Checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urgent/emergent relapse event rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complete response (no visible or microscopic bladder carcinoma)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percent weight loss at 6 and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure occurrence within 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: withdrawal related craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant satisfaction with the program
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sum of trans fatty acids in PE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Docosahexaenoic acid (DHA) values in PE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visual outcome on first postoperative day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Affected waking hours
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: osmolarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Na(+) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discharge Criteria effectiveness
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Skills scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Educational environment improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: onset time of vecuronium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak effect of vecuronium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean clearance (CL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: helpful first aid intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Geometric mean anti-CT IgG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response to HBV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response to OCV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CIWA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brachial-ankle pulse wave velocity (baPWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Standardised mortality ratio within 90 days of operation
Endpoint domain: Mortality/survival
Primary endpoint: end‐tidal CO2 pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Objective knowledge score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective knowledge score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decisional certainty
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptance of rape myths
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Tolerance of sexual harassment
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Erectile Function (EF) domain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved erections (positive response to GAQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical Global Impression improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gambling Symptom Rating Scale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of a‐CEP‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive a‐Sa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive a‐CarP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calibration of GAVS II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrimination of GAVS II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leukocyte counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amblyopia Treatment Index scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Protein C concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: nutritional indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insomnia severity reduction
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Instrumentation of root canal walls
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: endothelium dependent responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Asymmetry ratios of balance responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Functioning (PF) change scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Global Health Status (GHS) change scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: new clinical fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: deaths from any cause
Endpoint domain: Mortality/survival
Primary endpoint: 1-year peri-implant marginal bone level changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of implant and prosthesis failures
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of early prosthetic complications
Endpoint domain: Adverse events/effects
Primary endpoint: sizes of stromal infiltrates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sizes of epithelial defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DIAGNOdent readings after caries removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful re-enrollment in drug treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Positive urines for opiates and cocaine
Endpoint domain: Adverse events/effects
Primary endpoint: Pain relief at two hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of associated symptoms at two hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained 24 hour pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical health improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fullness sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: digestive well-being
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: new-onset cases of diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 1-year change of LTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean differences in percent change in lumbar spine BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreases in serum osteocalcin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreases in C-telopeptide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum Alveolar Concentration (MAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State Entropy (SE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to undergo TKA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Density of anterior stromal keratocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level during injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FSFI 'desire' score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in CBF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: BDI affective score correlation with FHAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dissatisfaction and episodes of crying
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Favorable outcome on the Glasgow Outcome Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: plasma glucagon-like peptide 1 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: plasma glucose responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TBC median log reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of NPO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean Absolute Error (MAE) in postoperative refraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: conditional weight gain from birth to 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight-for-length z-score at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMI z-score at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overweight at ages 1 and 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in supragingival anaerobic bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent reduction in LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percent reduction in TG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Definite/probable device thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Bone volume (BV) at T2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Family history of dilated cardiomyopathy (DCM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Minor side effects (nausea, vomiting, and pain)
Endpoint domain: Adverse events/effects
Primary endpoint: Cost advantage
Endpoint domain: Resource use
Primary endpoint: Scar quality improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: postbronchodilator FEV(1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean maximum concentration (Cmax) of fexofenadine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC) of fexofenadine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet collection efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: WBC contamination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Westergren erythrocyte sedimentation rate (ESR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: joint pain/tenderness index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of suggested missing IS-A relations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in modified Sharp/van der Heijde score at week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in ADAS-cog at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion classified as 'improved' using CIBIC
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Success rate of airway management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time taken to insert devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of difficulty encountered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in superoxide and total reactive oxygen species (ROS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: increase in myeloid DC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: decrease in monocyte gene expression of TNFα, IL‐6, TLR4 and serum GMCSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ventilation efficiency (VE/VCO2 slope)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Attitudes towards dairy products
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decreasing flow velocity in bilateral ACA, PCA and MCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Regional cerebral blood flow and regional cerebral blood volume in frontal lobes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ovulation achievement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of mild ovarian hyperstimulation syndrome (OHSS)
Endpoint domain: Adverse events/effects
Primary endpoint: Dose requirement for anticoagulant effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic clearance based on unbound drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average duration of treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postmeal glycemia AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postmeal insulinemia AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative incidence of PCE
Endpoint domain: Adverse events/effects
Primary endpoint: Delay in gastric emptying (τ(m))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ad26 NAb titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: EnvA-specific ELISA titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: EnvA-specific ELISPOT responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: quality of primary care depression therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: costs of case management
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of anisotropy reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VASR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid use (morphine equivalent)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Risk of low rate of weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of cataract surgery
Endpoint domain: Mortality/survival
Primary endpoint: Airway resistance mean scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: S(pO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean propulsive velocity at light loads
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BP velocity and SQ power at the heaviest load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of adverse side effects
Endpoint domain: Adverse events/effects
Primary endpoint: mean number of notifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RCT (Retinal Capillary Transit time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of consent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in Psoriasis Area and Severity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability Frequency Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Disability Limitation Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Withdrawal from exercise program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pooled incidence of nocebo responses
Endpoint domain: Adverse events/effects
Primary endpoint: Pooled nocebo severity
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of seroconversion to type 1 poliovirus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of subjects excreting type 1 poliovirus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of platelet CD62p
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average duration of relapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in hemidystonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of difficulty in opening mouth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative infant mortality at 7 months
Endpoint domain: Mortality/survival
Primary endpoint: HIV infection rates at 7 months
Endpoint domain: Mortality/survival
Primary endpoint: Platelet glycoprotein IIb/IIIa receptor occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of unused oxycodone tablets
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of insomnia
Endpoint domain: Adverse events/effects
Primary endpoint: Total fluoroscopy duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fluoroscopy exposure during puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maternal haemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes